In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $502.55, marking a +0.45% move from the previous day. The stock's change was more than the S&P 500's daily loss of 0.33%. At the ...

According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...

Hakimo has now raised a total of $20.5 million, including prior funding rounds led by Neotribe Ventures and Rocketship.vc.

AbbVie, Danaher, Thermo Fisher Scientific, Cognizant Technology Solutions, Vertex Pharmaceuticals, Alnylam Pharmaceuticals, ...

Gemini 2.5 Pro is a multimodal, reasoning model that outperforms competitors from OpenAI, Anthropic, and DeepSeek on key ...

Meinhard Regler, an expert in detector development and software analysis, passed away on 22 September 2024 at the age of 83.

Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Vertex's cloud growth momentum remains strong, with a 27% y/y increase in 4Q24. Read more to see why I upgrade VERX stock ...

Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of indirect tax technology solutions, reveals that while free, easy product returns are paramount for consumer loyalty, they ...

Explore Google's new Gemini 2.5 Pro's advanced AI features, from coding to ethical reasoning, and its transformative impact ...

Google released a new family of AI reasoning models on March 25 under the Gemini 2.5 models, beginning with the experimental ...

FDA approval of a novel non-opioid analgesic will hopefully address the needs of many patients with acute pain and improve ...